EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models

Shihui Shen, Qiansen Zhang, Yuhan Wang, Hui Chen, Shuangming Gong, Yun Liu, Conghao Gai, Hansen Chen, Enhao Zhu, Bo Yang, Lin Liu, Siyuan Cao und 12 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci185278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Shihui Shen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, Chi…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Proto-Oncogene Proteins p21(ras), Neoplasms, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmProto-Oncogene Proteins p21(ras)NeoplasmsProteasome Endopeptidase ComplexProteasome InhibitorsAutoantigensMice, Inbred C57BLMice, Inbred BALB CMice, NudeHumansMaleFemaleAnimalsMiceXenograft Model Antitumor AssaysMutationImmune Checkpoint InhibitorsNF-E2-Related Factor 2UbiquitinCell LineAntineoplastic Combined Chemotherapy ProtocolsGene Expression Regulation, NeoplasticSignal TransductionOrganoidsAdultMiddle Aged

Stichwörter der Autor:innen

CancerDrug therapyOncologyTherapeuticsTumor suppressors

Substanzen

Proto-Oncogene Proteins p21(ras)Immune Checkpoint InhibitorsNF-E2-Related Factor 2Proteasome Endopeptidase ComplexProteasome InhibitorsUbiquitinAutoantigenssotorasibPiperazinesPyridines

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.
  • Joint Center for Translational Medicine, Shanghai Fifth People's Hospital, Fudan University and School of Life Science, East China Normal University, Shanghai, China.
  • Organic Chemistry Group, College of Pharmacy, Naval Medical University, Shanghai, China.
  • School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China.
  • Health Science Center, East China Normal University, Shanghai, China.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Shen, S., Zhang, Q., Wang, Y., Chen, H., Gong, S., Liu, Y., Gai, C., Chen, H., Zhu, E., Yang, B., Liu, L., Cao, S., Zhao, M., Ren, W., Li, M., Peng, Z., Zhang, L., Zhang, S., Shen, J., …, & Yang, H. (2025). Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models. Journal of Clinical Investigation. https://doi.org/10.1172/jci185278

Vancouver

Shen S, Zhang Q, Wang Y, Chen H, Gong S, Liu Y, et al. Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models. Journal of Clinical Investigation. 2025. doi:10.1172/jci185278

BibTeX
@article{Shen2025,
  author = {Shen, Shihui and Zhang, Qiansen and Wang, Yuhan and Chen, Hui and Gong, Shuangming and Liu, Yun and Gai, Conghao and Chen, Hansen and Zhu, Enhao and Yang, Bo and Liu, Lin and Cao, Siyuan and Zhao, Mengting and Ren, Wenjie and Li, Mengjuan and Peng, Zhuoya and Zhang, Lu and Zhang, Shaoying and Shen, Juwen and Zhang, Bianhong and Lee, Patrick Kh and Li, Kun and Li, Lei and Yang, Huaiyu},
  title = {Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci185278}
}
Kostenlos starten →